AOP Orphan is now AOP Health
As of January 2022, all divisions and subsidiaries of AOP Orphan have been united under the AOP Health brand.
The new brand - AOP Health - emphasizes our patient-centric approach when developing integrated therapies for rare diseases and in critical care.
Dedicated to improving patients' lives
Our company has made a name for itself worldwide as the European pioneer in the field of rare diseases and in critical care. By founding OrphaCare in 2018 - now AOP Care - and taking over Amomed Pharma GmbH and SciPharm S.à.r.l. in 2020, we continued our systematic growth.
- cardiology & pulmonology
- critical care
- neurology & metabolic disorders
With one brand identity, we want to unite all areas of our group and put the focus on what is most important: Health.
There is a video embedded here from the social network Youtube/Vimeo. This content is currently blocked. There is no data exchange between your browser and the social network.
Needs. Science. Trust.
This claim underlines our dedication to developing integrated therapies in the field of rare diseases and in critical care, and making them available for patients worldwide. Improving their quality of life – whether it is rare diseases, critical care or 24/7 patient services – is and will remain our mission and motivation.
„With our new brand name, we want to express our commitment to our patients, which has remained unchanged for a quarter century."
Focus on integrated solutions
Our ever-growing integrated network of medical solutions will benefit patients, patient organizations, physicians, scientists and all healthcare professionals, who find a trusted and committed long-term partner in AOP Health.